Pharmacology
Parent Topic Collection:
Latest articles
- Restricted accessReplyEfficacy of Subcutaneous vs. Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the DetailsNisha A. Gilotra, Stuart D. RussellJACC: Heart Failure March 01, 2018, 6 (3) 267; DOI: 10.1016/j.jchf.2018.01.014
- Restricted accessEfficacy of Subcutaneous Versus Intravenous Administration of Furosemide in Patients With Worsening Heart FailureThe Devil Is in the DetailsJanani Rangaswami, Peter A. McCulloughJACC: Heart Failure March 01, 2018, 6 (3) 266-267; DOI: 10.1016/j.jchf.2018.01.010
- Restricted accessPhysicians Addicted to Prescribing Aspirin-a Disorder Of Cardiologists (PAPA-DOC) SyndromeThe Headache of Nonevidence-Based Medicine for Ischemic Heart Disease?John G.F. ClelandJACC: Heart Failure February 01, 2018, 6 (2) 168-171; DOI: 10.1016/j.jchf.2017.11.014
- Restricted accessLow-Dose Aspirin in Heart Failure Not Complicated by Atrial FibrillationA Nationwide Propensity-Matched StudyChristian Madelaire, Gunnar Gislason, Søren L. Kristensen, Emil L. Fosbøl, Jenny Bjerre, Maria D’Souza, Finn Gustafsson, Lars Kober, Christian Torp-Pedersen, Morten SchouJACC: Heart Failure February 01, 2018, 6 (2) 156-167; DOI: 10.1016/j.jchf.2017.09.021
- Restricted accessYet Another (Important) Goal for Heart Failure PatientsMarc A. SilverJACC: Heart Failure January 01, 2018, 6 (1) 49-51; DOI: 10.1016/j.jchf.2017.10.003
Review articles
- Restricted accessWorsening Heart Failure During the Use of DPP-4 InhibitorsPathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic MedicationsMilton PackerJACC: Heart Failure June 01, 2018, 6 (6) 445-451; DOI: 10.1016/j.jchf.2017.12.016
- Restricted accessPatients Not Meeting PARADIGM-HF Enrollment Criteria Are Eligible for Sacubitril/Valsartan on the Basis of FDA ApprovalThe Need to Close the GapAntonio L. Perez, Veraprapas Kittipibul, W.H. Wilson Tang, Randall C. StarlingJACC: Heart Failure June 01, 2017, 5 (6) 460-463; DOI: 10.1016/j.jchf.2017.03.007
- Restricted accessAntiplatelet and Anticoagulant Agents in Heart FailureCurrent Status and Future PerspectivesPaul A. Gurbel, Udaya S. TantryJACC: Heart Failure February 01, 2014, 2 (1) 1-14; DOI: 10.1016/j.jchf.2013.07.007
- Restricted accessDrug Therapy to Reduce Early Readmission Risk in Heart FailureReady for Prime Time?Muthiah Vaduganathan, Gregg C. Fonarow, Mihai GheorghiadeJACC: Heart Failure August 01, 2013, 1 (4) 361-364; DOI: 10.1016/j.jchf.2013.04.010
- Restricted accessNitrate Therapy for Heart FailureBenefits and Strategies to Overcome ToleranceDivya Gupta, Vasiliki V. Georgiopoulou, Andreas P. Kalogeropoulos, Catherine N. Marti, Clyde W. Yancy, Mihai Gheorghiade, Gregg C. Fonarow, Marvin A. Konstam, Javed ButlerJACC: Heart Failure June 01, 2013, 1 (3) 183-191; DOI: 10.1016/j.jchf.2013.03.003
Advertisement
Advertisement